These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6120856)

  • 61. Solubilization by proteolysis of an activated form of rat liver membrane guanylate cyclase.
    Lacombe ML; Haguenauer-Tsapis R; Stengel D; Ben Salah A; Hanoune J
    FEBS Lett; 1980 Jul; 116(1):79-84. PubMed ID: 6105969
    [No Abstract]   [Full Text] [Related]  

  • 62. Microinjections of cholinergic agonists into the intermediolateral cell column of the spinal cord at T1-T3 increase heart rate and contractility.
    Sundaram K; Murugaian J; Krieger A; Sapru H
    Brain Res; 1989 Nov; 503(1):22-31. PubMed ID: 2611655
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potassium release from the rat submaxillary gland in vitro. II. Induction by parasympathomimetic secretagogues.
    Martinez JR; Quissell DO
    J Pharmacol Exp Ther; 1976 Dec; 199(3):518-25. PubMed ID: 136510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cholinergic effects on intracellular free calcium concentration in renal corpuscle: role of parietal sheet.
    Lebrun F; Morel F; Vassent G; Marchetti J
    Am J Physiol; 1992 Feb; 262(2 Pt 2):F248-55. PubMed ID: 1539686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subcellular localization of guanylate cyclase.
    Kimura H; Murad F
    Life Sci; 1975 Sep; 17(6):837-43. PubMed ID: 568
    [No Abstract]   [Full Text] [Related]  

  • 66. Low insulin concentrations stimulate in vitro the soluble guanylate cyclase activity of rat liver.
    Laurenza A; Paolisso G; Chiosi E; Spina AM; Illiano G
    Biochem Biophys Res Commun; 1983 Jul; 114(1):282-8. PubMed ID: 6136276
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Purification of guanylate cyclase from rat liver supernatant.
    Tsai SC; Manganiello VC; Vaughan M
    J Biol Chem; 1978 Dec; 253(23):8542-7. PubMed ID: 30779
    [No Abstract]   [Full Text] [Related]  

  • 68. Guanylate cyclase in the excitable ciliary membrane of Paramecium.
    Schultz JE; Klumpp S
    FEBS Lett; 1980 Dec; 122(1):64-6. PubMed ID: 6111470
    [No Abstract]   [Full Text] [Related]  

  • 69. Atropine combined with carbachol for promotion ofngastric peristalsis.
    DIJKEN BG; de WIED D
    Acta Radiol (Stockh); 1961 Jun; 55():449-57. PubMed ID: 13722872
    [No Abstract]   [Full Text] [Related]  

  • 70. [Guanylate cyclase activity of human adipocytes].
    Lecot F; Levilliers J; Pairault J; Laudat MH
    Biochimie; 1981 Jan; 63(1):45-52. PubMed ID: 6111358
    [No Abstract]   [Full Text] [Related]  

  • 71. Changes in the functional activity of membrane-bound guanylate cyclase forms in tissues of diabetic rats.
    Shpakov AO; Derkach KV; Chistyakova OV; Pertseva MN
    Dokl Biochem Biophys; 2010; 433():219-22. PubMed ID: 20714861
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of ethanol administration on guanylate cyclase activities in liver and brain.
    Miki N; Nagano M; Kuriyama K
    Jpn J Pharmacol; 1977 Apr; 27(2):322-5. PubMed ID: 18634
    [No Abstract]   [Full Text] [Related]  

  • 73. The effect of acetylcholine, carbaminoylcholine and atropine on oxygen consumption and blood lactic acid in rabbits.
    LUNDHOLM L
    Acta Pharmacol Toxicol (Copenh); 1959; 15(3):244-50. PubMed ID: 13636874
    [No Abstract]   [Full Text] [Related]  

  • 74. Cholinergic mechanism involved in function of mesodiencephalic activating system.
    RINALDI F; HIMWICH HE
    AMA Arch Neurol Psychiatry; 1955 Apr; 73(4):396-402. PubMed ID: 14360857
    [No Abstract]   [Full Text] [Related]  

  • 75. Alerting responses and actions of atropine and cholinergic drugs.
    RINALDI F; HIMWICH HE
    AMA Arch Neurol Psychiatry; 1955 Apr; 73(4):387-95. PubMed ID: 14360856
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of cholinergic agents on rat liver plasma membrane guanylate cyclase.
    Lippo de Becemberg I; Herrera V; Perez Ayuso E; Alfonzo M
    FEBS Lett; 1982 Jan; 137(2):303-6. PubMed ID: 6120856
    [No Abstract]   [Full Text] [Related]  

  • 77. Myocardial guanylate cyclase: properties of the enzyme and effects of cholinergic agonists in vitro.
    Limbird LE; Lefkowitz RJ
    Biochim Biophys Acta; 1975 Jan; 377(1):186-96. PubMed ID: 235292
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Muscarinic agents modify kinetics properties of membrane-bound guanylyl cyclase activity.
    Lippo de Becemberg I; Peña de Aguilar AE; Camarillo I; Gonzalez de Alfonzo R; Alfonzo M
    FEBS Lett; 1989 Aug; 253(1-2):16-22. PubMed ID: 2569412
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Release of enzymes from a rat liver lysosome fraction: inhibition by catecholamines and cyclic3', 5'-adenosine monophosphate, stimulation by cholinergic agents and cyclic 3', 5'-guanosine monophosphate.
    Ignarro LJ; Krassikoff N; Slywka J
    J Pharmacol Exp Ther; 1973 Jul; 186(1):86-99. PubMed ID: 4353102
    [No Abstract]   [Full Text] [Related]  

  • 80. Occupancy of muscarinic acetylcholine receptors stimulates a guanylate cyclase in neuroblastoma cells.
    Strange PG; Birdsall NJ; Burgen AS
    Biochem Soc Trans; 1977; 5(1):189-91. PubMed ID: 19315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.